Comparison of Intravenous Bolus with Infusion Regimen of Oxytocin in Patients Undergoing Elective Cesarean Delivery
Intravenous Bolus with Infusion Regimen of Oxytocin and Elective Cesarean Delivery
DOI:
https://doi.org/10.54393/pjhs.v7i3.3675Keywords:
Oxytocin, Intravenous Bolus, Continuous Infusion, Cesarean Delivery, Postpartum Hemorrhage, Uterine Tone, Hemodynamic Stability, Hypotension, Tachycardia, Maternal OutcomesAbstract
Postpartum hemorrhage is one of the leading causes of maternal mortality, and its rate of occurrence increases with the increase in the rates of cesarean section. The main prophylaxis is oxytocin, although the best way to administer it (intravenous bolus or continuous infusion) is the most effective and safe. Objectives: To compare the effectiveness and safety of intravenous bolus with the infusion regimen of oxytocin in patients undergoing elective cesarean delivery. Methods: The quasi-experimental study compared intravenous oxytocin bolus versus continuous infusion for the prevention of postpartum hemorrhage in women undergoing elective cesarean section. Ninety term pregnant women (ASA I–II) were allocated to receive either a 3 IU IV bolus followed by infusion or a 10 IU continuous infusion. The primary outcome was postpartum hemorrhage, while secondary outcomes included uterine tone, additional uterotonic requirement, hemodynamic stability, and maternal side effects. Data were analyzed using SPSS version 26.0, with p<0.05 considered statistically significant. Results: The incidence of postpartum hemorrhage was similar in the bolus (4.4%) and infusion (2.2%) groups (p=0.78), with no significant difference in uterine atony or mean blood loss, indicating comparable uterotonic efficacy. However, hypotension and tachycardia were significantly more frequent in the bolus group (p=0.02 and p=0.03, respectively). Conclusions: Intravenous oxytocin bolus and infusion are equally effective in preventing postpartum hemorrhage and maintaining uterine tone during elective cesarean section; however, continuous infusion offers superior maternal hemodynamic stability with significantly lower rates of hypotension and tachycardia, making it the safer regimen.
References
Nagai A, Shiko Y, Noguchi S, Ikeda Y, Kawasaki Y, Mazda Y. Protocolized Oxytocin Infusion for Elective Cesarean Delivery: A Retrospective Before-and-After Study. Journal of Anesthesia. 2024 Aug; 38(4): 425-33. doi: 10.1007/s00540-024-03329-1. DOI: https://doi.org/10.1007/s00540-024-03329-1
Boonstra L, Carvalho JC, Turner W, Downey K, Ye XY, Thomas J et al. Maintenance Infusion Rate of Oxytocin After Initial 1-IU Bolus for Elective Cesarean Delivery: A Dose-Finding Study. Canadian Journal of Anesthesia/Journal canadien d'anesthésie. 2024 Oct; 71(10): 1363-71. doi: 10.1007/s12630-024-02828-9. DOI: https://doi.org/10.1007/s12630-024-02828-9
Chaudhuri P, Banerjee GB, Mandal A. Rectally Administered Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery to Reduce Intraoperative and Postoperative Blood Loss. International Journal of Gynecology and Obstetrics. 2010 Apr; 109(1): 25-9. doi: 10.1016/j.ijgo.2009.11.009. DOI: https://doi.org/10.1016/j.ijgo.2009.11.009
Zagrodnik E, Ziętek M, Machałowski T, Dołęgowska B, Szczuko M. Carbetocin Is More Effective in Stabilizing Hemodynamic Parameters Compared to Oxytocin During Cesarean Section. Biomedicines. 2025 Mar; 13(3): 685. doi: 10.3390/biomedicines13030685. DOI: https://doi.org/10.3390/biomedicines13030685
Brzozowska M, Lisiecki D, Kowalska-Koprek U, Karowicz-Bilińska A. Comparison of Carbetocin and Oxytocin Effectiveness for Prevention of Postpartum Hemorrhage After Caesarean Delivery. Ginekologia Polska. 2015; 86(2). doi: 10.17772/gp/1996. DOI: https://doi.org/10.17772/gp/1996
El-Goly NA, Maged AM, Kamal WM, Hosny O, Turki D, Helmy NM. Carbetocin versus Oxytocin in Prevention of Postpartum Hemorrhage After Cesarean Delivery in High-Risk Women. A Systematic Review and Meta-Analysis. Archives of Gynecology and Obstetrics. 2025 Apr: 1-9. doi: 10.1007/s00404-025-08014-6. DOI: https://doi.org/10.1007/s00404-025-08014-6
Gabr AA. Pre-Incisional Oxytocin Infusion in Elective Cesarean Section Delivery, Maternal and Neonatal Outcome. The Egyptian Journal of Fertility and Sterility. 2023 May; 27(3): 22-33. doi: 10.21608/egyfs.2023.303254. DOI: https://doi.org/10.21608/egyfs.2023.303254
Heesen M, Carvalho B, Carvalho JC, Duvekot JJ, Dyer RA, Lucas DN et al. International Consensus Statement on the Use of Uterotonic Agents During Caesarean Section. Anesthesia. 2019 Oct; 74(10): 1305-19. doi: 10.1111/anae.14757. DOI: https://doi.org/10.1111/anae.14757
Kureshi FR, Gupta S, Rajani B, Patel U, Patel MR. Efficacy of Phenylephrine in Preventing Hemodynamic Responses of Oxytocin During Caesarean Section Under Spinal Anesthesia: A Randomized Comparative Study. International Journal of Medical Anesthesiology. 2025 Jan; 8(1): 20. doi: 10.33545/26643766.2025.v8.i1a.541. DOI: https://doi.org/10.33545/26643766.2025.v8.i1a.541
El Tahan MR, Warda OM, Rashad A, Yasseen AM, Ramzy EA, Ahmady MS et al. Effects of Preoperative Sublingual Misoprostol on Uterine Tone During Isoflurane Anesthesia for Cesarean Section. Revista Brasileira de Anestesiologia. 2012; 62: 630-5. doi: 10.1590/S0034-70942012000500003. DOI: https://doi.org/10.1590/S0034-70942012000500003
Akpan UB, Ugwuoke O, Ekpo E, Omoronyia E, Ekabua J, Ekabua Sr J. Effectiveness of Combined Preoperative Sublingual Misoprostol and Intravenous Tranexamic Acid on Intraoperative Blood Loss During Elective Caesarean Section: A Randomised, Blinded, Placebo-Controlled Trial. Cureus. 2023 Jun; 15(6). doi: 10.7759/cureus.41041. DOI: https://doi.org/10.7759/cureus.41041
Goel V, Karya U, Rani A, Dayal M, Goel Sr V. Hemodynamic and Uterotonic Effects of Carbetocin Versus Oxytocin in a Cesarean Section with a High Risk of Postpartum Hemorrhage. Cureus. 2025 May; 17(5). doi: 10.7759/cureus.83504. DOI: https://doi.org/10.7759/cureus.83504
Çetin Ç, Dural HR, Özcan P, Tanoğlu FB, Kütük MS, Pasin Ö et al. The Efficacy of Three Regimes of Uterotonic Agents for Prevention of Postpartum Blood Loss at Undergoing Cesarean Section: A Prospective Randomized Clinical Trial. Ginekologia Polska. 2023; 94(9): 741-7. doi: 10.5603/gpl.93374. DOI: https://doi.org/10.5603/gpl.93374
Balki M and Wong CA. Refractory Uterine Atony: Still A Problem After All These Years. International Journal of Obstetric Anesthesia. 2021 Nov; 48: 103207. doi: 10.1016/j.ijoa.2021.103207. DOI: https://doi.org/10.1016/j.ijoa.2021.103207
Sheehan SR, Montgomery AA, Carey M, McAuliffe FM, Eogan M, Gleeson R et al. Oxytocin Bolus versus Oxytocin Bolus and Infusion for Control of Blood Loss at Elective Caesarean Section: Double Blind, Placebo Controlled, Randomized Trial. British Medical Journal. 2011 Aug; 343. doi: 10.1136/bmj.d4661. DOI: https://doi.org/10.1136/bmj.d4661
M Mahmoud M, El-Garhey I, A El-Boghdady A. A Comparative Study Between Oxytocin Intravenous Bolus Versus Oxytocin Intravenous Bolus and Infusion for Control of Blood Loss at Elective Cesarean Section. Al-Azhar Medical Journal. 2021 Jan; 50(1): 419-32. doi: 10.21608/amj.2021.139734. DOI: https://doi.org/10.21608/amj.2021.139734
Hasanin A, Habib S, Abdelwahab Y, Elsayad M, Mostafa M, Zayed M et al. Variable Versus Fixed-Rate Infusion of Phenylephrine During Cesarean Delivery: A Randomized Controlled Trial. BioMed Central Anesthesiology. 2019 Nov; 19(1): 197. doi: 10.1186/s12871-019-0879-3. DOI: https://doi.org/10.1186/s12871-019-0879-3
Albazee E, Soliman A, Albakri K, Elbanna M, Moussa NA, Faragalla HM. Efficacy and Safety of Rectal Misoprostol Versus Intravenous Oxytocin on Reducing Blood Loss in Cesarean Section: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Clinical Trials. Turkish Journal of Obstetrics and Gynecology. 2023 Jun; 20(2): 142-53. doi: 10.4274/tjod.galenos.2023.15098. DOI: https://doi.org/10.4274/tjod.galenos.2023.15098
Ravichandrane B, Subramaniam R, Muthiah T, Talawar P, Ramadurai R. Comparison of Prophylactic Infusion of Phenylephrine Versus Norepinephrine for the Prevention of Post Spinal Hypotension in Parturients Undergoing Elective Caesarean Section-A Randomized, Double-Blinded, Non-Inferiority Trial. Turkish Journal of Anesthesiology and Reanimation. 2023 Jun; 51(3): 213. doi: 10.4274/TJAR.2022.22909. DOI: https://doi.org/10.4274/TJAR.2022.22909
Archer TL, Knape K, Liles D, Wheeler AS, Carter B. The Hemodynamics of Oxytocin and Other Vasoactive Agents During Neuraxial Anesthesia for Cesarean Delivery: Findings in Six Cases. International Journal of Obstetric Anesthesia. 2008 Jul; 17(3): 247-54. doi: 10.1016/j.ijoa.2008.03.003. DOI: https://doi.org/10.1016/j.ijoa.2008.03.003
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
